[breadcrumb_custom]

AUTL’s Stochastic Averages Dip: Analyzing Autolus Therapeutics plc ADR’s Stock Performance

The market performance of Autolus Therapeutics plc ADR has been somewhat stable. Over the past year, the company’s stock achieved a high of $7.45 on 01/12/24, with the lowest value for the same timeframe being $1.61, recorded on 04/26/23.

52-week price history of AUTL Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Autolus Therapeutics plc ADR’s current trading price is -22.08% away from its 52-week high, while its distance from the 52-week low is 260.56%. The stock’s price range during this period has fluctuated between $1.61 and $7.45. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 4.5 million for the day, which was evidently higher than the average daily volume of 1.23 million over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Financial Performance and Market Capitalization

Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly rise of 57.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.01B and boasts a workforce of 399 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.36, with a change in price of +3.00. Similarly, Autolus Therapeutics plc ADR recorded 969,349 in trading volume during the last 100 days, posting a change of +104.62%.

AUTL Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AUTL stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.26.

AUTL Stock Stochastic Average

The raw stochastic average for Autolus Therapeutics plc ADR over the last 50 days is presently at 64.07%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 22.68%. Further, the company’s Stochastic %K and %D values for the last 20 days were 38.77% and 41.19%, respectively.

AUTL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -9.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 94.15%. Over the past 30 days, the price of AUTL has leaped by -15.13%. And in the last five days, it has fallen by -2.11%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts